Refractory CRPS pain treated with psilocybin: A case report.
Clinical case reports
September 1, 2024
David S Jevotovsky et al. (5 authors)
Case ReportsJournal ArticleHuman Study
Study Details
Study Goal
The researchers aimed to evaluate psilocybin's potential as a treatment for Complex Regional Pain Syndrome (CRPS) in a patient with refractory symptoms.
Results Summary
The study found that psilocybin provided significant pain relief and functional improvement in the patient, suggesting its potential efficacy for chronic pain management.
Population
A single patient with refractory CRPS.
Effective Dosage
Not available
Duration
Not specified
Interactions
None mentioned
Extracted Claims (3)
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Psilocybin | neutral | CRPS | - | - | shows promise as a treatment | #1 |
Psilocybin | decrease | pain | a patient with refractory symptoms | - | offering significant pain relief | #2 |
Psilocybin | increase | functional improvement | a patient with refractory symptoms | - | functional improvement | #3 |
Abstract
Psilocybin shows promise as a treatment for CRPS, offering significant pain relief and functional improvement in a patient with refractory symptoms. This case highlights the need for further research into psilocybin's efficacy and optimal dosing for chronic pain management.
Study Links
PubMed ID39281029
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality40/10
Citation Metrics
Total Citations3
Citations/Year3.0
Research Impact Scores
APT Score0.75
Weight Score2.13
Normalized Score0.58
Related Supplements